Synthesis and antifungal photodynamic activities of a series of novel zinc(II) phthalocyanines substituted with piperazinyl moieties

被引:42
作者
Zheng, Bi-Yuan [1 ]
Zhang, Hong-Peng [1 ]
Ke, Mei-Rong [1 ]
Huang, Jian-Dong [1 ]
机构
[1] Fuzhou Univ, Coll Chem & Chem Engn, Fuzhou 350108, Peoples R China
关键词
Zinc(II) phthalocyanine; Photosensitizer; Photodynamic therapy; Single oxygen; Antifungal; Candida albicans; ANTIMICROBIAL CHEMOTHERAPY PACT; OXYGEN QUANTUM YIELDS; CANDIDA-ALBICANS; FLUORESCENCE-SPECTRA; CATIONIC PORPHYRIN; METHYLENE-BLUE; THERAPY; INACTIVATION; PHOTOSENSITIZERS; MICROORGANISMS;
D O I
10.1016/j.dyepig.2013.04.032
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A series of novel zinc(II) phthalocyanines tetra-substituted or mono-substituted with piperazinyl moieties linked by different ethoxy chains has been prepared and characterized. The effects of the N-protecting group of piperazinyl moiety, length of ethoxy chains and number of substitutes on the photophysical, photochemical properties, cellular uptakes and in vitro photodynamic antifungal activities have also been examined. All of these compounds are essentially non-aggregated and good singlet oxygen generators with quantum yields (Phi(Delta)) of 0.54-0.77 in N,N-dimethylformamide. The photodynamic activity of these compounds against Candida albicans follows the order: 7 > 5a > 5b > 4a approximate to 4h. The mono-substituted phthalocyanine 7 exhibits the highest photodynamic inactivation of C albicans with an IC90 value of 9 mu M, which can be attributed to its better amphiphilicity and even higher cellular uptake. The results suggest that phthalocyanine 7 is a potential photosensitizer for antifungal photodynamic therapy. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 36 条
  • [1] The present and future role of photodynamic therapy in cancer treatment
    Brown, SB
    Brown, EA
    Walker, I
    [J]. LANCET ONCOLOGY, 2004, 5 (08) : 497 - 508
  • [2] Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
    Celli, Jonathan P.
    Spring, Bryan Q.
    Rizvi, Imran
    Evans, Conor L.
    Samkoe, Kimberley S.
    Verma, Sarika
    Pogue, Brian W.
    Hasan, Tayyaba
    [J]. CHEMICAL REVIEWS, 2010, 110 (05) : 2795 - 2838
  • [3] Synthesis and antimycotic activity of new unsymmetrical substituted zinc phthalocyanines
    Cosimelli, B
    Roncucci, G
    Dei, D
    Fantetti, L
    Ferroni, F
    Ricci, M
    Spinelli, D
    [J]. TETRAHEDRON, 2003, 59 (50) : 10025 - 10030
  • [4] Phthalocyanines as photodynamic agents for the inactivation of microbial pathogens
    Dei, Donata
    Chiti, Giacomo
    De Filippis, Maria P.
    Fantetti, Lia
    Giuliani, Francesco
    Giuntini, Francesca
    Soncin, Marina
    Jori, Giulio
    Roncucci, Gabrio
    [J]. JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2006, 10 (03) : 147 - 159
  • [5] Photodynamic therapy for cancer
    Dolmans, DEJGJ
    Fukumura, D
    Jain, RK
    [J]. NATURE REVIEWS CANCER, 2003, 3 (05) : 380 - 387
  • [6] Antifungal photodynamic therapy
    Donnelly, Ryan F.
    McCarron, Paul A.
    Tunney, Michael M.
    [J]. MICROBIOLOGICAL RESEARCH, 2008, 163 (01) : 1 - 12
  • [7] Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O
    Donnelly, Ryan F.
    McCarron, Paul A.
    Tunney, Michael M.
    Woolfson, A. David
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2007, 86 (01) : 59 - 69
  • [8] Photodynamic therapy
    Dougherty, TJ
    Gomer, CJ
    Henderson, BW
    Jori, G
    Kessel, D
    Korbelik, M
    Moan, J
    Peng, Q
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12): : 889 - 905
  • [9] Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009)
    Espinel-Ingroff, Ana
    [J]. REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (01): : 15 - 22
  • [10] Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
    Gelderblom, H
    Verweij, J
    Nooter, K
    Sparreboom, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1590 - 1598